Erlotinib (Tarceva) appears in one listed tablet product, Tarceva.
First-line Treatment of Locally Advanced or Metastatic Non-small Cell Lung Cancer with Egfr Activating Mutations
100mg
Blocks epidermal growth factor receptor tyrosine kinase to stop cancer cells from growing and spreading in non-small cell lung cancer and pancreatic cancer.
Related medicines appear within Oncology Support.
Information about Erlotinib on this page is an educational overview, not medical advice. Products can differ in formulation, strength, and directions, and this content does not authorise clinical application or unsupervised use. Review the labelling for each product and speak with a healthcare professional whenever clinical judgement is needed. Product-specific contraindications, interactions, and reactions should be checked in the product labelling and verified clinical sources.
